MoneyWorks4Me

NATCO Pharma informs about press release

20 Jan 2022 Evaluate

Pursuant to the Regulation 30 of SEBI (LODR) Regulations, 2015, NATCO Pharma has informed that it enclosed the Press Release on January 20,2022 titled ‘NATCO announces License Agreement with the Medicines Patent Pool’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..